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Syphilis, the “great imitator” of skin diseases, remains a public health problemworldwide. Coinfection by
the human immunodeﬁciency virus (HIV) and syphilis is common and has important clinical conse-
quences. HIV infection may alter the classical clinical course and manifestations of syphilis. We herein
report two young men who presented with fever and generalized ulceronecrotic lesions, which mimic
hemorrhagic chicken pox, eczema herpeticum, or vasculitis. Malignant syphilis (lues maligna) was
diagnosed according to clinical presentation, serology, and pathology. HIV infection was subsequently
conﬁrmed later. Excellent resolution of skin lesion was achieved after appropriate antibiotics therapy.
Copyright  2014, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Syphilis, a sexually transmitted disease caused by the spirochete
Treponema pallidum, can mimic a variety of skin conditions. It is
well-known that syphilis increases the risk of human immunode-
ﬁciency virus (HIV) transmission, and HIV infection, in turn, can
alter the natural history and clinical manifestations of syphilis.1
Malignant syphilis (lues maligna) is a rare presentation of sec-
ondary syphilis, and most reported cases are associated with con-
current HIV infection.2,3 We herein describe two cases of lues
maligna present initially in HIV-infected young men.Case Reports
Case 1
A 22-year-old man presented to our emergency department with a
1-week history of painless skin lesions. According to the patient,
the skin lesions initially appeared as small erythematous papules
over his face and gradually spread to the trunk and extremities.s of interest relevant to this
y, Mackay Memorial Hospital,
i 10449, Taiwan.
u@gmail.com (Y.-H. Wu).
cal Association. Published by ElsevSome papular lesions became centrally ulcerated or necrotic. The
patient also experienced fever, weight loss, headache, nausea,
vomiting, increased lethargy, and poor appetite during the past 1
month.
On examination, the patient appeared ill, febrile, and pale. Skin
lesions consisted of multiple nontender, nonpruritic, erythematous
papuloplaques, somewith a necrotic center, and ulcers covered by a
dark rupioid crust on the face, trunk, and four limbs (Figure 1).
There was no involvement of mucous membranes or genitalia.
Marked cervical lymphadenopathy was also noted.
Results of Tzanck smear revealed neither multinucleated giant
cells nor balloon cells. Complete blood count revealed the
following: hemoglobin level of 13.7 g/dL; decreased leukocyte
count (3.6  103/mm3; 41% neutrophils, 45% lymphocytes, and 1%
atypical lymphocytes); and platelet count of 1.1 105/mm3. Results
of biochemical study showed elevated levels of serum aspartate
aminotransferase (152 U/L; normal, 15e40 U/L) and alanine
aminotransferase (238 U/L; normal, 15e40 U/L). HBsAg, anti-HBc
immunoglobulin M (IgM), and hepatitis C antibody were nega-
tive. Results of renal function, C-reactive protein, antinuclear anti-
body, complement 3 (C3), and antineutrophil cytoplasmic antibody
tests were normal.
Initially, the patient was administered with an intravenous in-
jection of levoﬂoxacin at the emergency room for possible atypical
infection. However, the condition did not improve and a derma-
tology consultationwas requested. Serology blood tests for syphilis,ier Taiwan LLC. All rights reserved.
Figure 1 Multiple erythematous papuloplaques with necrotic center or crusted ulcers on (A) face, (B) upper limbs, and (C) lower limbs. Blisters can be seen in some lesions.
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tions of the skin samples from the right forearm revealed ulcera-
tion, spongiosis, and marked dermal edema. The epidermal cells
near the ulceration showed psoriasiform hyperplasia. In the dermis,
a superﬁcial and deep, perivascular and interstitial inﬁltrate of
neutrophils, lymphocytes, histiocytes, and some plasma cells was
identiﬁed. Necrotizing vasculitis with ﬁbrinoid necrosis and
endothelium swelling were also noted. Although the results of
periodic acideSchiff, acid-fast, and WarthineStarry staining were
negative, syphilis serology test results later demonstrated a rapid
plasma reagin (RPR) titer of 1:4 and a T. pallidum hemagglutination
assay (TPHA) titer of 1:320. Tissue cultures for fungi, bacteria, and
mycobacterium were unremarkable.
Based on all these ﬁndings, the patient was diagnosed with
malignant syphilis (lues maligna). Results of both HIV serological
test and HIV enzyme-linked immunosorbent assay (ELISA)
showed positive ﬁndings, which were conﬁrmed by HIV Western
blot. The patient had a CD4 count of 360 cells/mm3 and the HIV
viral load was 3187 copies/mL. The patient refused a lumbar
puncture, and treatment was started with intravenous aqueous
penicillin G injection (24 million units/day in divided doses,
every 6 hours) for 2 weeks. JarischeHerxheimer reaction (JHR)
did not occur during treatment. The therapy resulted in rapid
regression of the skin lesions and systemic symptoms several
days later (Figure 2). However, this patient was lost to follow-up
after discharge.Case 2
A 26-year-old homosexual man without systemic disease was
admitted to the hospital because of skin rash and fever of un-
known origin for 3 weeks. The patient was in good condition until
approximately 3 weeks prior to presentation, when mild itchy skin
rashes were noted on the anterior chest. Two days after the pre-
sentation of skin lesions, the patient developed intermittent fever
up to 38C with occasional chillness. Besides, the rashes progres-
sively spread to the whole body including the four limbs, face, and
genital organs. One week prior to admission, the patient devel-
oped malaise, myalgia, arthralgia at the knee and ankle joints, and
sore throat. Moreover, the patient reported unintentional weight
loss of approximately 3 kg during the previous 1 month.
Physical examination in the emergency room showed an acute
ill-looking appearance with multiple nontender, nonpruritic
erythematous papulovesicles on the face, trunk, and four limbs
including palms and soles (Figures 3Ae3C). A complete blood count
showed leukopenia (white blood cells 2000/mL) and anemia (Hb:
9.7 g/dL). Measurement of electrolyte levels, results of renal func-
tion tests and liver function tests were all normal; autoimmune
disease proﬁle for antinuclear factor, antidouble-stranded DNA, C3,
and C4, and infection survey for Amoeba, Cryptococcus, hepatitis C
virus, hepatitis B virus, toxoplasma IgG/IgM were negative; uri-
nalysis showed normal ﬁnding. The patient was not allergic to
medicine before, and denied any drug abuse history; however, he
Figure 2 Skin lesions of (A) forehead and (B) upper limbs improved dramatically after
5 days of intravenous penicillin therapy.
Figure 3 Multiple disseminated erythematous papules and nodules with purpur
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reported no ingestion of raw food, exposure to sick patients or
animals, or recent travel.
Initially, intravenous ciproﬂoxacin and aqueous penicillin G
were administered. A dermatologist was consulted. An abdominal
skin biopsy was performed. Histopathological analysis revealed
microabscess, acanthosis, spongiosis, and scattered dyskeratotic
cells in the epidermis (Figure 4A). A diffuse and dense lympho-
histiocytic inﬁltrate was present in the upper and middle dermis.
Numerous plasma cells were present in the inﬂammation
(Figure 4B). Periodic acideSchiff and acid-fast stains were negative
for infectious organisms. WarthineStarry silver stain demonstrated
many spirochetes in the epidermis (Figure 4C). Syphilis serology
test later demonstrated an RPR titer of 1:512, and a TPHA titer of
1:20,480. The patient was diagnosed as a case of malignant syphilis
(lues maligna). HIV serology and HIV ELISA both showed positive
ﬁndings, which were conﬁrmed by HIV Western blot. The CD4
count was 88 cells/mm3 and the HIV viral load was 189,400 copies/
mL. The patient was treated with intravenous aqueous penicillin G
injection (12 million units/day in divided doses, every 6 hours) and
ciproﬂoxacin. The therapy resulted in rapid regression of the pap-
ulovesicular lesions (Figure 5A). However, toxic epidermal necrol-
ysis, which presented as generalized erythematous erosions and
bullae, developed 7 days after initiating aqueous penicillin G and
ciproﬂoxacin therapy (Figures 5A and 5B). He was admitted to the
burn intensive care unit, and ciproﬂoxacin therapy was withdrawn.
However, the patient completed 18 days of aqueous penicillin G
injection and was under supported care. The patient recovered
without sequelae and was discharged from the hospital (Figure 5C).
The RPR titer dropped to 1:8 after penicillin treatment 3 months
later.ic center on the (A) trunk, (B) lower limb, (C) dorsal hands, and (D) palms.
Figure 4 Histopathological results of skin biopsy. (A) Microabscess, acanthosis, spongiosis, and scattered dyskeratotic cells in the epidermis. Diffuse and dense inﬂammatory
inﬁltrating cells are present in the upper and middle dermis. (B) Numerous plasma cells are present in the inﬂammation. (C) WarthineStarry silver stain demonstrates many
spirochetes in the epidermis.
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Syphilis and HIV are both sexually transmitted diseases and share
similar risk factors. In HIV-infected patients it has been reported
that syphilis shows atypical clinical and serological features, un-
reliable response to therapy, and premature development of neu-
rosyphilis.4 By contrast, syphilis causes increases in the HIV viral
load and decreases in the CD4 cell counts in HIV-seropositive pa-
tients.4,5 It is recommended that all patients presenting with
syphilis should be offered HIV testing and vice versa.6Figure 5 (A) Seven days after admission, the initially scattered erythematous papulovesicl
erosions and bullae formation on the trunk and limbs. (C) Twenty days after admission, buMalignant syphilis is a rare form of secondary syphilis. The
disease is characterized by a prodrome of fever, headache, and
myalgia followed by generalized papulopustular eruptions that
rapidly evolve into necrotic ulcers covered by a dark, rupioid crust.
Scalp and face are most commonly involved. The risk of malignant
syphilis has been linked to host immune status.7 In the pre-AIDS
era, <1% of all syphilitic cases were reported to be associated
with severe malnutrition, chronic alcoholism, and diabetes melli-
tus.8With the advent of the AIDS pandemic, however, the incidence
of this variant of syphilis has increased.8 Recently, the majority ofes improved and only hyperpigmented macules were left. (B) Diffused erythema with
llae were healing but some hyperpigmented patches and macules remained.
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groups.2,9 A multicenter retrospective study of 11,368 HIV-
infected patients in Germany found that 151 (1.3%) patients were
concurrently infected with syphilis, and 11 (7.3%) of them had
malignant syphilis.4
Histopathological examination of skin lesions in lues maligna
reveals epidermal necrosis, dense perivascular, and interstitial in-
ﬂammatory cells inﬁltrated with lymphocytes and plasma cells, and
often with involvement of vessels. Vascular changes include
endothelial swelling, proliferation, hyaline thrombi, and ﬁbrinoid
deposition.10 The specimen of our Patient 1 did not show dense
inﬁltration of plasma cells, which might be due to the biopsy of an
early lesion, as seen in previous reports.10 Spirochete is rarely
identiﬁed in skin biopsy specimens of malignant syphilis.11 The
reasons may be attributed to the paucity of spirochetes in skin
specimens and the low sensitivity of WarthineStarry silver stain.11
There were only six published cases in the English literature of
pathologically conﬁrmed malignant syphilis in HIV-infected
patients.11
Syphilis is often called “the great imitator” because of diverse
clinical manifestations. The appearance of these two cases neces-
sitates differential diagnosis with a variety of other entities,
including disseminated varicella zoster,11 herpes simplex, menin-
gococcemia, ecthyma,12 deep cutaneous mycosis, cutaneous
tuberculosis, atypical mycobacterial infection, Wegener’s gran-
ulomatosis, pityriasis lichenoides et varioliformis acuta, pyoderma
gangrenosum, lymphomatoid papulosis, or even cutaneous lym-
phoma.8 Diagnostic criteria for malignant syphilis are a strongly
positive RPR titer, a severe JHR, characteristic gross andmicroscopic
morphology, and rapid resolution of lesions with antibiotics.13 In
our patients, the diagnosis was conﬁrmed by the positive RPR/
TPHA titers, characteristic clinical lesions, a compatible pathology
ﬁnding, and rapid resolution of the diffuse rashes with penicillin.
The absence of JHR in our patients may be related to their con-
current immunosuppression.11,13
Despite the name “malignant”, malignant syphilis usually re-
sponds very rapidly to proper therapy. HIV-infected patients should
be treated in accordance with the same recommendations as forHIV-uninfected patients.1,5,6 In Patient 1, neurosyphilis could not be
excluded, especially because he had intermittent headache, nausea,
and vomiting. However, Patient 1 refused a lumbar puncture, and
we treated him as a case of neurosyphilis.
In conclusion, the rarity of malignant syphilis and its unusual
clinical manifestations presented a challenge to the clinician.
Clinical and pathologic awareness is necessary for correct diagnosis
of this rare disease, and its presence should alert the provider to
consider HIV co-infection.References
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